Yearly Archives: 2025

IPO’s Comments to China’s NMPA on the “Implementation Measures for the Protection of Drug Trial Data” and the “Working Procedures for the Protection of Drug Trial Data.”

IPO’s Comments to China’s NMPA on the "Implementation Measures for [...]

By |2025-06-09T12:34:16-04:00May 18th, 2025|Testimony and Comments|Comments Off on IPO’s Comments to China’s NMPA on the “Implementation Measures for the Protection of Drug Trial Data” and the “Working Procedures for the Protection of Drug Trial Data.”